Trotter JL, Hendin BA, Osterland CK. Cerebellar Degeneration With Hodgkin Disease. Arch Neurol. 1976;33:660–1. https://doi.org/10.1001/archneur.1976.00500090066014.
Article CAS PubMed Google Scholar
de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, Lugtenburg PJ, Hoogenraad CC, Sillevis SP. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71:815–24. https://doi.org/10.1002/ana.23550.
Article CAS PubMed Google Scholar
Graus F, Humayun Gultekin S, Ferrer I, Reiriz J, Alberch J, Dalmau J. Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin’s disease in the rat nervous system. Acta Neuropathol. 1998;96:1–7. https://doi.org/10.1007/s004010050853.
Article CAS PubMed Google Scholar
Peter E, Do LD, Hannoun S, Muniz-Castrillo S, Vogrig A, Wucher V, Pinto AL, Chounlamountri N, Zakaria W, Rogemond V, Picard G, Hedou JJ, Ambati A, Alentorn A, Traverse-Glehen A, Manto M, Psimaras D, Mignot E, Cotton F, Desestret V, Honnorat J, Joubert B. Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features. Neurol Neuroimmunol Neuroinflamm. 2022;9. https://doi.org/10.1212/NXI.0000000000200018.
Cai Y, Liu J, Ren H, Shi F, Che J, Geng Q, Tan Y, Guan H, Di W. Anti-Tr/DNER antibody-associated cerebellar ataxia: three rare cases report and literature review. Neurol Sci. 2023;44:397–403. https://doi.org/10.1007/s10072-022-06389-x.
Campana IG, Silva GD. Considering a new clinical presentation of the anti-Tr/DNER antibody-associated cerebellar ataxia. Neurol Sci. 2023;44:1099. https://doi.org/10.1007/s10072-022-06503-z.
Campana IG, Silva GD. Anti-Tr/DNER Antibody-Associated Cerebellar Ataxia: a Systematic Review. Cerebellum. 2022;21:1085–91. https://doi.org/10.1007/s12311-021-01346-4.
Article CAS PubMed Google Scholar
Barba C, Alexopoulos H, Dimitriadou M, Akrivou S, Tsiortou P, Plomaritoglou A, Dalakas M. Anti- Tr antibodies in autoimmune cerebellar ataxia: Serial antibody testing and response to immunotherapy (P2.2–039). 2019;92:P2.-039. https://n.neurology.org/content/92/15_Supplement/P2.2-039.abstract
Greene M, Lai Y, Baella N, Dalmau J, Lancaster E. Antibodies to Delta/Notch-like Epidermal Growth Factor–Related Receptor in Patients With Anti-Tr, Paraneoplastic Cerebellar Degeneration, and Hodgkin Lymphoma. JAMA Neurol. 2014;71. https://doi.org/10.1001/jamaneurol.2014.999.
Bernal F, Shams’ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, Honnorat J, Smitt PS, Graus F. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology. 2003;60:230–4. https://doi.org/10.1212/01.wnl.0000041495.87539.98
Wirtz PW, Willcox N, van der Slik AR, Lang B, Maddison P, Koeleman BPC, Giphart MJ, Wintzen AR, Roep BO, Verschuuren JJGM. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome. J Neuroimmunol. 2005;159:230–7. https://doi.org/10.1016/j.jneuroim.2004.10.018.
Article CAS PubMed Google Scholar
Titulaer MJ, Lang B, Verschuuren JJGM. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10:1098–107. https://doi.org/10.1016/s1474-4422(11)70245-9.
Pellkofer H, Armbruster L, Krumbholz M, Titulaer M, Verschuuren J, Schumm F, Voltz R. Lambert-Eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel. J Neuroimmunol. 2008;204:136–9. https://doi.org/10.1016/j.jneuroim.2008.08.002.
Article CAS PubMed Google Scholar
Yiannopoulou K, Vakrakou AG, Anastasiou A, Nikolopoulou G, Sourdi A, Tzartos JS, Kilidireas C, Dimitrakopoulos A. Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review. Diagnostics. 2023;13. https://doi.org/10.3390/diagnostics13122055.
留言 (0)